Based on these studies and our current results we hypothesize that reprogramming the immunosuppressive and lymphocyte-excluding myeloid cells through anti-MARCO treatment can be a potential approach to re-recruit immune effector cells to the tumor area and convert cold tumors into hot tumors. Here, MARCO is linked to neoplasm.